INVESTIGATION OF THE ROLE OF TACHYKININ NK1, NK2 RECEPTORS AND CGRP RECEPTORS IN NEUROGENIC PLASMA-PROTEIN EXTRAVASATION IN DURA-MATER

被引:21
作者
OSHAUGHNESSY, CT
CONNER, HE
机构
[1] Pharmacology 2 Department, Glaxo Research and Development Ltd., Ware
关键词
PLASMA PROTEIN EXTRAVASATION; DURA MATER; TACHYKININ NK1 RECEPTOR; ALPHA-CGRP-(8-37); GR82334;
D O I
10.1016/0014-2999(94)90541-X
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The aim of this study was to investigate the role of tachykinin NK1 and NK2 receptors, and calcitonin gene-related peptide (CGRP) receptors in neurogenic plasma protein extravasation, induced by electrical stimulation of the trigeminal ganglion, in dura mater of anaesthetised rats and guinea-pigs. This response was significantly (P < 0.05) blocked in both species by the selective peptide tachykinin NK1 receptor antagonist, GR82334 ([D-Pro(9)[spiro-gamma-lactam]Leu(10),Trp(11)]physalaemin-(1-11)) (0.02-0.2 mg/kg i.v.) whilst the selective tachykinin NK2 receptor antagonist, (+/-)-SR 48968 ((S)-N-methyl-N-[4-(4-acetylamino-4-phenylpiperidino)-2-(3,4-dichlorophenyl) buty] benzamide) (1 mg/kg i.v.) was without effect. The CGRP receptor antagonist, alpha-CGRP-(8-37) (0.1 mg/kg i.v.) significantly (P < 0.05) blocked this response in dura mater of guinea-pigs but not rats. These results suggest that substance P, acting via tachykinin NK1 rather than NK2 receptors, mediates neurogenic plasma protein extravasation in dura mater and that CGRP may have an involvement in this response in guinea-pigs.
引用
收藏
页码:193 / 198
页数:6
相关论文
共 16 条
[1]  
ALAFACI C, 1989, NEW ADV HEADACHE RES, P105
[2]  
BALL DI, 1992, NEUROPEPTIDE, V22, P5
[3]  
BRAIN SD, 1985, BRIT J PHARMACOL, V86, P885
[4]   THE ANTIMIGRAINE DRUG, SUMATRIPTAN (GR43175), SELECTIVELY BLOCKS NEUROGENIC PLASMA EXTRAVASATION FROM BLOOD-VESSELS IN DURA MATER [J].
BUZZI, MG ;
MOSKOWITZ, MA .
BRITISH JOURNAL OF PHARMACOLOGY, 1990, 99 (01) :202-206
[5]   A POTENT AND SELECTIVE NONPEPTIDE ANTAGONIST OF THE NEUROKININ-A (NK2) RECEPTOR [J].
EMONDSALT, X ;
VILAIN, P ;
GOULAOUIC, P ;
PROIETTO, V ;
VANBROECK, D ;
ADVENIER, C ;
NALINE, E ;
NELIAT, G ;
LEFUR, G ;
BRELIERE, JC .
LIFE SCIENCES, 1992, 50 (15) :PL101-PL106
[6]   EFFECT OF A CALCITONIN-GENE-RELATED PEPTIDE ANTAGONIST (CGRP8-37) ON SKIN VASODILATATION AND EDEMA INDUCED BY STIMULATION OF THE RAT SAPHENOUS NERVE [J].
ESCOTT, KJ ;
BRAIN, SD .
BRITISH JOURNAL OF PHARMACOLOGY, 1993, 110 (02) :772-776
[7]   HUMAN ALPHA-CALCITONIN GENE-RELATED PEPTIDE (CGRP)-(8-37), BUT NOT (CGRP)-(28-37), INHIBITS CAROTID VASODILATOR EFFECTS OF HUMAN ALPHA-CGRP INVIVO [J].
GARDINER, SM ;
COMPTON, AM ;
KEMP, PA ;
BENNETT, T ;
BOSE, C ;
FOULKES, R ;
HUGHES, B .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1991, 199 (03) :375-378
[8]   VASOACTIVE PEPTIDE RELEASE IN THE EXTRACEREBRAL CIRCULATION OF HUMANS DURING MIGRAINE HEADACHE [J].
GOADSBY, PJ ;
EDVINSSON, L ;
EKMAN, R .
ANNALS OF NEUROLOGY, 1990, 28 (02) :183-187
[9]  
HAGAN RM, 1991, BRIT J PHARMACOL, V102, pP168
[10]   CALCITONIN GENE-RELATED PEPTIDE - FUNCTIONAL-ROLE IN CEREBROVASCULAR REGULATION [J].
MCCULLOCH, J ;
UDDMAN, R ;
KINGMAN, TA ;
EDVINSSON, L .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (15) :5731-5735